Can the targeted use of a discharge pharmacist significantly decrease 30-day readmissions?
about
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysisNurses' communication of pharmacogenetic test results as part of discharge careMedication Reconciliation Practices in Canadian Emergency Departments: A National Survey.Evaluation of a Pharmacist-Specific Intervention on 30-Day Readmission Rates for High-Risk Patients with Pneumonia.Effect of Pharmacy-Supported Transition-of-Care Interventions on 30-Day Readmissions: A Systematic Review and Meta-analysis.Person-centred pharmaceutical care reduces emergency readmissions.Impact of an Integrated Pharmacy Transitions of Care Pilot Program in an Urban Hospital.Incorporating a Pharmacist Into the Discharge Process: A Unit-Based Transitions of Care Pilot.Reducing Medical Admissions into Hospital through Optimising Medicines (REMAIN HOME) Study: protocol for a stepped-wedge, cluster-randomised trial.Analysis of an electronic medication reconciliation and information at discharge programme for frail elderly patients.Nurses' attitudes and behaviors on patient medication educationWhat is polypharmacy? A systematic review of definitions.Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).Evaluation of a medication intensity screening tool used in malignant hematology and bone marrow transplant services to identify patients at risk for medication-related problems.Medication safety at the interface: evaluating risks associated with discharge prescriptions from mental health hospitals.Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients.
P2860
Q28066489-EBA14E0F-E672-4868-B906-8E367D0F5266Q35317242-3ECE90EC-9BC0-4CB0-B495-6C5CC8934A97Q35797853-9589A910-56FA-402E-AB50-D6C18AADE1F6Q36391502-7BA6D3C8-6297-4AF8-9631-5B9D75A1C043Q36397114-4C0C5092-BC33-4E19-B9F8-56307308C9D5Q36681871-CDE711DA-9BA7-4033-93F2-4ABC25EA6E00Q38368413-81BD7527-2E23-43D1-8BCA-FD5BE97A075CQ38996300-1099D8C6-8F96-48C0-9B4A-D07EA4DC7AA8Q39241602-BF7B724F-9916-4AF3-ACDD-488EE795C57FQ39680726-10231451-906B-4B55-A7E8-9F5746EC4899Q40952832-96270635-F925-4BC2-B5BE-31C46AF3658EQ42374534-676C5D04-AC1A-41BC-B536-F1B65303B5EEQ47178286-13120BBA-116C-4151-93EA-1465E794FFEDQ47183951-375FE506-1872-4656-A8B1-CCA19C5BFF33Q50556653-A6F28118-F5C2-453A-93CD-73C7C8ED2FEBQ53113770-2AFF8F7D-6A1D-4294-9FF7-9DA863A32E38
P2860
Can the targeted use of a discharge pharmacist significantly decrease 30-day readmissions?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Can the targeted use of a disc ...... decrease 30-day readmissions?
@en
Can the targeted use of a disc ...... decrease 30-day readmissions?
@nl
type
label
Can the targeted use of a disc ...... decrease 30-day readmissions?
@en
Can the targeted use of a disc ...... decrease 30-day readmissions?
@nl
prefLabel
Can the targeted use of a disc ...... decrease 30-day readmissions?
@en
Can the targeted use of a disc ...... decrease 30-day readmissions?
@nl
P2093
P2860
P356
P1433
P1476
Can the targeted use of a disc ...... decrease 30-day readmissions?
@en
P2093
Samaneh Tavalali Wilkinson
Stewart Babbott
P2860
P304
P356
10.1310/HPJ4805-380
P577
2013-05-01T00:00:00Z